Protecting Medical Devices/Equipment and Healthcare Technology
BSKB is back with our fourth annual Medical Technology IP Seminar! This webinar covers current patent issues in medical technology and the healthcare field. We will discuss recent developments at the Patent Trial and Appeal Board and the Court of Appeals for the Federal Circuit and their effect on obtaining patent rights for medical technology.
The webinar will not cover patenting of inventions relating to pharmaceutical products, but instead will focus on medical-related inventions with a significant electronic, imaging, mechanical, data processing, chemical and biotechnological component to the invention.
The webinar will have native English and Japanese speakers; each lecturer being an attorney, U.S. patent agent or Japanese benrishi. English and Japanese language slides will be provided.
Date:
October 10, 2024
Time:
9:30 am - 11:00 am (JST)
Cost: Free
Location:
Zoom (link provided upon registration)
Who Should Attend?
- In-house counsel, technical advisors, and IP Coordinators from Japanese law firms and companies working in the medical technology and/or healthcare field, with a specialization in intellectual property focusing on medical-related inventions with a significant mechanical, electrical or data processing component
- Japanese Patent Attorneys, agents, and students who are interested in gaining a deeper understanding of how to prosecute patent applications in the medical technology field
*IMPORTANT: This webinar is intended for Japanese audiences, or those with a professional understanding of the Japanese language, as half of the webinar will be presented in Japanese!
Topics Covered
- the impact of In re Cellect and Allergan USA v. MSN Labs on continuation practice when family members have differing expiration dates due to Patent Term Adjustment,
- the effect of Medtronic v. Teleflex (Fed. Cir. 2024) considering claim construction of the order of performance of method steps,
- a discussion of the recent PTAB decision of Masimo Corp v. Apple Inc. compared with the Federal Circuit decision in LKQ Corp v. GM Global Technology regarding applying the KSR standard to design patents, and
- a discussion of USPTO's recent issuance of AI subject matter eligibility guidance and review of new examples.
